{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:18:40Z","timestamp":1795112320060,"version":"4.10.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:00:00Z","timestamp":1604102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:00:00Z","timestamp":1604102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1038\/s41431-020-00748-y","type":"journal-article","created":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T12:02:53Z","timestamp":1604145773000},"page":"402-410","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":143,"title":["Estimation of the number of people with Down syndrome in Europe"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4990-5711","authenticated-orcid":false,"given":"Gert","family":"de Graaf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9708-2705","authenticated-orcid":false,"given":"Frank","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5232-9882","authenticated-orcid":false,"given":"Brian G.","family":"Skotko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,31]]},"reference":[{"key":"748_CR1","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/gim.2016.97","volume":"18","author":"AR Gregg","year":"2016","unstructured":"Gregg AR, Skotko BG, Benkendorf JL, Monaghan KG, Bajaj K, Best RG, et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2016;18:1056\u201365.","journal-title":"Genet Med"},{"key":"748_CR2","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1097\/AOG.0000000000001439","volume":"127","author":"Committee on Practice Bulletins\u2014Obstetrics, Committee on Genetics, and the Society for Maternal-Fetal Medicine","year":"2016","unstructured":"Committee on Practice Bulletins\u2014Obstetrics, Committee on Genetics, and the Society for Maternal-Fetal Medicine. Practice bulletin no. 163 summary: screening for fetal Aneuploidy. Obstet Gynecol. 2016;127:979\u201381.","journal-title":"Obstet Gynecol"},{"key":"748_CR3","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ajmg.a.37001","volume":"167","author":"G de Graaf","year":"2015","unstructured":"de Graaf G, Buckley F, Skotko BG. Estimates of the live births, natural losses, and elective terminations with Down syndrome in the United States. Am J Med Genet A. 2015;167:756\u201367.","journal-title":"Am J Med Genet A"},{"key":"748_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/gim.2016.127","volume":"19","author":"G de Graaf","year":"2017","unstructured":"de Graaf G, Buckley F, Skotko BG. Estimation of the number of people with Down syndrome in the United States. Genet Med. 2017;19:439\u201347.","journal-title":"Genet Med"},{"key":"748_CR5","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1471-0528.2008.01700.x","volume":"115","author":"PA Boyd","year":"2008","unstructured":"Boyd PA, Devigan C, Khoshnood B, Loane M, Garne E, Dolk H, et al. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down\u2019s syndrome. BJOG Int J Obstet Gynaecol. 2008;115:689\u201396.","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"748_CR6","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.2105\/AJPH.2005.069377","volume":"96","author":"B Khoshnood","year":"2006","unstructured":"Khoshnood B, De Vigan C, Vodovar V, Br\u00e9art G, Goffinet F, Blondel B. Advances in medical technology and creation of disparities: the case of Down syndrome. Am J Public Health. 2006;96:2139\u201344.","journal-title":"Am J Public Health"},{"key":"748_CR7","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1002\/ajmg.a.36780","volume":"164A","author":"JK Morris","year":"2014","unstructured":"Morris JK, Garne E, Wellesley D, Addor M-C, Arriola L, Barisic I, et al. Major congenital anomalies in babies born with Down syndrome: a EUROCAT population-based registry study. Am J Med Genet A. 2014;164A:2979\u201386.","journal-title":"Am J Med Genet A"},{"key":"748_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/ejhg.2012.94","volume":"21","author":"M Loane","year":"2013","unstructured":"Loane M, Morris JK, Addor M-C, Arriola L, Budd J, Doray B, et al. Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening. Eur J Hum Genet. 2013;21:27\u201333.","journal-title":"Eur J Hum Genet"},{"key":"748_CR9","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators.","year":"2018","unstructured":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Lond Engl. 2018;392:1789\u2013858.","journal-title":"Lancet Lond Engl"},{"key":"748_CR10","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1468-3148.2010.00593.x","volume":"24","author":"G de Graaf","year":"2011","unstructured":"de Graaf G, Vis JC, Haveman M, van Hove G, de Graaf EAB, Tijssen JGP, et al. Assessment of prevalence of persons with down syndrome: a theory-based demographic model. J Appl Res Intellect Disabil. 2011;24:247\u201362.","journal-title":"J Appl Res Intellect Disabil"},{"key":"748_CR11","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ejhg.2012.294","volume":"21","author":"J Wu","year":"2013","unstructured":"Wu J, Morris JK. The population prevalence of Down\u2019s syndrome in England and Wales in 2011. Eur J Hum Genet. 2013;21:1016\u20139.","journal-title":"Eur J Hum Genet"},{"key":"748_CR12","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/ejhg.2013.104","volume":"21","author":"J Wu","year":"2013","unstructured":"Wu J, Morris JK. Erratum: the population prevalence of Down\u2019s syndrome in England and Wales in 2011. Eur J Hum Genet. 2013;21:1033\u20134.","journal-title":"Eur J Hum Genet"},{"key":"748_CR13","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/jir.12277","volume":"60","author":"M Alexander","year":"2016","unstructured":"Alexander M, Ding Y, Foskett N, Petri H, Wandel C, Khwaja O. Population prevalence of Down\u2019s syndrome in the United Kingdom. J Intellect Disabil Res. 2016;60:874\u20138.","journal-title":"J Intellect Disabil Res"},{"key":"748_CR14","first-page":"64","volume":"15","author":"JL Zhu","year":"2013","unstructured":"Zhu JL, Hasle H, Correa A, Schendel D, Friedman JM, Olsen J, et al. Survival among people with Down syndrome: a nationwide population-based study in Denmark. Genet Med J Am Coll Med Genet. 2013;15:64\u201369.","journal-title":"Genet Med J Am Coll Med Genet"},{"key":"748_CR15","unstructured":"Quinones J, August 14 ALCN, 2017, Pm 4:00. \u2018What kind of society do you want to live in?\u2019: Inside the country where Down syndrome is disappearing. https:\/\/www.cbsnews.com\/news\/down-syndrome-iceland\/ (accessed 13 Jan 2020)."},{"key":"748_CR16","first-page":"459","volume":"18","author":"G de Graaf","year":"2016","unstructured":"de Graaf G, Buckley F, Skotko BG. Live births, natural losses, and elective terminations with Down syndrome in Massachusetts. Genet Med J Am Coll Med Genet. 2016;18:459\u201366.","journal-title":"Genet Med J Am Coll Med Genet"},{"key":"748_CR17","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1002\/ajmg.a.38402","volume":"173","author":"G de Graaf","year":"2017","unstructured":"de Graaf G, Buckley F, Dever J, Skotko BG. Estimation of live birth and population prevalence of Down syndrome in nine U.S. states. Am J Med Genet A. 2017;173:2710\u20139.","journal-title":"Am J Med Genet A"},{"key":"748_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/jms.9.1.2","volume":"9","author":"JK Morris","year":"2002","unstructured":"Morris JK, Mutton DE, Alberman E. Revised estimates of the maternal age specific live birth prevalence of Down\u2019s syndrome. J Med Screen. 2002;9:2\u20136.","journal-title":"J Med Screen"},{"key":"748_CR19","unstructured":"United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects:The 2017 Revision, DVD Edition. https:\/\/population.un.org\/wpp\/Download\/Standard\/Fertility\/ (accessed 9 Nov 2018)."},{"key":"748_CR20","unstructured":"United Nations, Department of Economic and Social Affairs, Statistic Division. Demographic Yearbook System. https:\/\/unstats.un.org\/unsd\/demographic-social\/products\/dyb\/#statistics (accessed 7 Jun 2018)."},{"key":"748_CR21","unstructured":"EUROCAT. Table A5 - Down Syndrome (per 10,000 births). https:\/\/eu-rd-platform.jrc.ec.europa.eu\/eurocat\/eurocat-data\/prevalence (accessed 4 Jul 2018)."},{"key":"748_CR22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1192\/bjp.95.400.685","volume":"95","author":"LS Penrose","year":"1949","unstructured":"Penrose LS. The incidence of mongolism in the general population. J Ment Sci. 1949;95:685\u20138.","journal-title":"J Ment Sci"},{"key":"748_CR23","unstructured":"World Health Organization. Raw data files of the WHO Mortality Database. https:\/\/www.who.int\/healthinfo\/statistics\/mortality_rawdata\/en\/ (accessed 17 Sep 2019)."},{"key":"748_CR24","unstructured":"International Monetary Fund. World Economic Outlook Database April 2019. https:\/\/www.imf.org\/external\/pubs\/ft\/weo\/2019\/01\/weodata\/index.aspx (accessed 3 Mar 2020)."},{"key":"748_CR25","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/ajmg.a.61438","volume":"182","author":"NM Crombag","year":"2020","unstructured":"Crombag NM, Page-Christiaens GC, Skotko BG, de Graaf G. Receiving the news of Down syndrome in the era of prenatal testing. Am J Med Genet A. 2020;182:374\u201385.","journal-title":"Am J Med Genet A"},{"key":"748_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-14-437","volume":"14","author":"YE Vellinga","year":"2014","unstructured":"Crombag NMTH, Vellinga YE, Kluijfhout SA, Bryant LD, Ward PA, Iedema-Kuiper R, et al. Explaining variation in Down\u2019s syndrome screening uptake: comparing the Netherlands with England and Denmark using documentary analysis and expert stakeholder interviews. BMC Health Serv Res. 2014;14:437.","journal-title":"BMC Health Serv Res"},{"key":"748_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","volume":"15","author":"IT Lott","year":"2019","unstructured":"Lott IT, Head E. Dementia in Down syndrome: unique insights for Alzheimer disease research. Nat Rev Neurol. 2019;15:135\u201347.","journal-title":"Nat Rev Neurol"},{"key":"748_CR28","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1001\/jamaneurol.2018.3616","volume":"76","author":"R Hithersay","year":"2019","unstructured":"Hithersay R, Startin CM, Hamburg S, Mok KY, Hardy J, Fisher EMC, et al. Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years. JAMA Neurol. 2019;76:152\u201360.","journal-title":"JAMA Neurol"},{"key":"748_CR29","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/aogs.13841","volume":"99","author":"K Gadsb\u00f8ll","year":"2020","unstructured":"Gadsb\u00f8ll K, Petersen OB, Gatinois V, Strange H, Jacobsson B, Wapner R, et al. Current use of noninvasive prenatal testing in Europe, Australia and the USA: a graphical presentation. Acta Obstet Gynecol Scand. 2020;99:722\u201330.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"748_CR30","unstructured":"Book (eISB) electronic IS. electronic Irish Statute Book (eISB). http:\/\/www.irishstatutebook.ie\/eli\/2018\/act\/31\/enacted\/en\/html (accessed 21 Sep 2020)."},{"key":"748_CR31","unstructured":"The Abortion (Northern Ireland) Regulations 2020. https:\/\/www.legislation.gov.uk\/uksi\/2020\/345\/contents\/made (accessed 21 Sep 2020)."}],"updated-by":[{"DOI":"10.1038\/s41431-022-01124-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000}}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-020-00748-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-020-00748-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-020-00748-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T05:15:27Z","timestamp":1655442927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-020-00748-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,31]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["748"],"URL":"https:\/\/doi.org\/10.1038\/s41431-020-00748-y","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,31]]},"assertion":[{"value":"16 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41431-022-01124-8","URL":"https:\/\/doi.org\/10.1038\/s41431-022-01124-8","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr BGS occasionally consults on the topic of Down syndrome through Gerson Lehrman Group. He receives remuneration from Down syndrome non-profit organizations for speaking engagements and associated travel expenses. Dr BGS receives annual royalties from Woodbine House, Inc., for the publication of his book, <i>Fasten Your Seatbelt: A Crash Course on Down Syndrome for Brothers and Sisters<\/i>. Within the past 2 years, he has received research funding from F. Hoffmann-La Roche, Inc. and LuMind IDSC\u00a0Down Syndrome Foundation to conduct clinical trials for people with Down syndrome. Dr BGS is occasionally asked to serve as an expert witness for legal cases where Down syndrome is discussed. Dr BGS serves in a non-paid capacity on the Honorary Board of Directors for the Massachusetts Down Syndrome Congress and the Professional Advisory Committee for the National Center for Prenatal and Postnatal Down Syndrome Resources. Dr BGS has a sister with Down syndrome. Dr GdG had a daughter with DS, who passed away in 2005 at the age of 15. He works as science and education officer at the Dutch Down Syndrome Foundation, a non-profit organization. FB serves a CEO of Down Syndrome Education International and Down Syndrome Education USA, nonprofits engaged in research and support for young people with Down syndrome. He has a sister with Down syndrome.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}